iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
No Identified Association Between Glecaprevir/Pibrentasvir Use and Risk of Hepatic Decompensation in HCV-Infected Patients With Compensated Cirrhosis at Baseline: An Active Comparator Cohort Study
 
  Hep Dart 2019, December 8-12, 2019, Kauai, Hawaii
Reported by Jules Levin
 
Lani R Wegrzyn1,2, Carrie Huisingh1,2, Ariel Porcalla2, Lino Rodrigues3, Margaret Burroughs3, Meenal Patwardhan2, Andrew Campbell3, Ryan D Kilpatrick1,21AbbVie Global Epidemiology, North Chicago, Illinois, United States; 2AbbVie Pharmacovigilance and Patient Safety, North Chicago, Illinois, United States; 3AbbVie Clinical Development, North Chicago, Illinois, United States

1212191

1212192

1212193

1212194

1212195

1212196

1212197

1212198

1212199

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org